ENOVIS CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.18 USD | +1.67% |
|
+1.37% | +0.45% |
Presenter SpeechMichael Matson (Analysts)[Audio Gap] Come to me at needhamco.com, and I'll try...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
Calendar
2024-05-02
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
55.26
USD
Average target price
75.2
USD
Spread / Average Target
+36.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.45% | 3.03B | |
| +13.01% | 128B | |
| -8.76% | 10.65B | |
| +3.60% | 8.82B | |
| +18.83% | 7.19B | |
| +21.81% | 4.99B | |
| +7.34% | 3.4B | |
| -4.80% | 2.14B | |
| -4.72% | 2B | |
| -22.91% | 1.79B |
- Stock Market
- Equities
- ENOV Stock
- News Enovis Corporation
- Transcript : Enovis Corporation Presents at 23rd Annual Needham Virtual Healthcare Conference, Apr-09-2024 03
